Product Information
LORAZEPAM 2 MG/ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.9254 per ML under NDC 00641620725. Its NADAC has been published 80 times since Dec 18, 2024.
Strength
2 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641620725
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
LORAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA018140On Market Since
7/25/1980
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG/ML VIAL has been published 80 times since Dec 18, 2024, and over the history we have for it it has risen 76.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9254 per ML |
|---|---|
| All-time high | $1.9254 (Jun 24, 2026) |
| All-time low | $1.0891 (Dec 18, 2024) |
| 52-week high | $1.9254 |
| 52-week low | $1.0891 |
| Median price | $1.0891 |
| Average price | $1.2183 |
| Largest weekly change | +54.6% (Mar 18, 2026) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG/ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $1.9254 per ML (NDC 00641620725), effective Jun 24, 2026.
How has the price of LORAZEPAM 2 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG/ML VIAL has risen 76.8%. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG/ML VIAL?
Since Dec 18, 2024, the NADAC for LORAZEPAM 2 MG/ML VIAL has ranged from a low of $1.0891 (Dec 18, 2024) to a high of $1.9254 (Jun 24, 2026), with a median of $1.0891 per ML.
Are there cheaper alternatives to LORAZEPAM 2 MG/ML VIAL?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LORAZEPAM 2 MG/ML ORAL CONCENT, is $0.6470 per ML — about 66% below LORAZEPAM 2 MG/ML VIAL.
Who manufactures LORAZEPAM 2 MG/ML VIAL?
LORAZEPAM 2 MG/ML VIAL (NDC 00641620725) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification